Browsing by Yonsei Author : Lee, Byung Wan

eperson profile image
Name:
Lee, Byung Wan [이병완]
orcid http://orcid.org/0000-0002-9899-4992
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (15763315600)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 196

This table browses all dspace content
Issue DateTitleJournal Title
2022Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease DIABETES & METABOLISM JOURNAL
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2022The effects of the voglibose on non-alcoholic fatty liver disease in mice model SCIENTIFIC REPORTS
2022Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model Endocrinology and Metabolism(대한내분비학회지)
2022Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy FRONTIERS IN ENDOCRINOLOGY
2022Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018 Endocrinology and Metabolism(대한내분비학회지)
2022Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double-blind, and placebo-controlled studyDIABETES OBESITY & METABOLISM
2022Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver diseaseHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
2022Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes YONSEI MEDICAL JOURNAL
2022SOLUTION study: Effect of gemigliptin as add-on therapy to dapagliflozin plus metformin in patients with type 2 diabetesDIABETES RESEARCH AND CLINICAL PRACTICE
2022Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 FRONTIERS IN IMMUNOLOGY
2022Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort StudyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2022Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trialDIABETES OBESITY & METABOLISM
2022Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) BMC MEDICINE
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease JAMA NETWORK OPEN
2022Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2021Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes FRONTIERS IN CARDIOVASCULAR MEDICINE
2021Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetesDIABETES RESEARCH AND CLINICAL PRACTICE
2021Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway DIABETES & METABOLISM JOURNAL
20212021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association DIABETES & METABOLISM JOURNAL
2021Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study DIABETES & METABOLISM JOURNAL
2021Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetesDIABETES OBESITY & METABOLISM
2021Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD) LIFE-BASEL
2021Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trialDIABETES OBESITY & METABOLISM
2021Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2020Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea Endocrinology and Metabolism(대한내분비학회지)
2020Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2020Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
2020Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial CLINICAL THERAPEUTICS
2020Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression SCIENTIFIC REPORTS
2020Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database DIABETES & METABOLISM JOURNAL
2020Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease CLINICAL AND MOLECULAR HEPATOLOGY
2020Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes MEDICINE
2020Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association DIABETES & METABOLISM JOURNAL
2020Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study CARDIOVASCULAR DIABETOLOGY
2020SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease NATURE COMMUNICATIONS
2020Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes SCIENTIFIC REPORTS
2020Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2020Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskAMERICAN JOURNAL OF GASTROENTEROLOGY
2020Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis JOURNAL OF CLINICAL MEDICINE
2020Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial JOURNAL OF CLINICAL MEDICINE
2020Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes Journal of Lipid and Atherosclerosis
2020Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study JOURNAL OF CLINICAL MEDICINE
2019A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor DIABETES & METABOLISM JOURNAL
2019Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes MellitusTRANSPLANTATION PROCEEDINGS
2019The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis JOURNAL OF CLINICAL MEDICINE
2019Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis DIABETES THERAPY
2019Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus SCIENTIFIC REPORTS
2019Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea DIABETES & METABOLISM JOURNAL

Browse

Links